Topic: breast cancer diagnostics
Natera is teaming up with two English universities to study the detection of breast cancer recurrence using ctDNA.
Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a nanosystem that uses "quantum dots" to improve the imaging of human tumors in mice.
Owlstone Medical and Cancer Research UK have begun a clinical trial designed to identify biomarkers of cancer in breath samples.
Guardant Health filed suit against Foundation Medicine in a U.S. District Court in California for false advertising and unfair competition.
HTG Molecular Diagnostics is teaming up with Spain’s Instituto Valenciano de Oncología to develop a score to predict breast cancer recurrence.
Philips is partnering with PathAI to improve the speed and accuracy of cancer diagnosis.
Cancer blood test business Biocept has priced shares and warrants worth an anticipated $9.3 million.
Myriad Genetics is rolling out a test for early-stage breast cancer that gauges the risk of recurrence after surgery and identifies patients who can skip chemo.
Freenome has raised $65 million in a round led by Andreessen Horowitz to put its cancer-detection tests through more rigorous trials.